Format

Send to

Choose Destination
Pediatr Res. 2012 Apr;71(4 Pt 2):411-7. doi: 10.1038/pr.2011.55. Epub 2012 Jan 25.

Emerging uses for pediatric hematopoietic stem cells.

Author information

1
Section of Cardiac Surgery, Children's Mercy Hospital and Clinics, Kansas City, Missouri, USA. adomen@cmh.edu

Abstract

Many new therapies are emerging that use hematopoietic stem and progenitor cells. In this review, we focus on five promising emerging trends that are altering stem cell usage in pediatrics: (i) The use of hematopoietic stem cell (HSC) transplantation, autologous or allogeneic, in the treatment of autoimmune disorders is one. (ii) The use of cord blood transplantation in patients with inherited metabolic disorders such as Hurler syndrome shows great benefit, even more so than replacement enzyme therapy. (iii) Experience with the delivery of gene therapy through stem cells is increasing, redefining the potential and limitations of this therapy. (iv) It has recently been shown that human immunodeficiency virus (HIV) infection can be cured by the use of selected stem cells. (v) Finally, it has long been postulated that HSC-transplantation can be used to induce tolerance in solid-organ transplant recipients. A new approach to tolerance induction using myeloid progenitor cells will be described.

PMID:
22278186
DOI:
10.1038/pr.2011.55
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Nature Publishing Group
Loading ...
Support Center